Comparison between modern rapid immunochromatographic strips and traditional methods for detecting Candida albicans, Trichomonas vaginalis, and Neisseria gonorrhea in Kerbala and Babylon cities detecting Candida albicans, Trichomonas vaginalis, and Neisseria gonorrhea in Kerbala and Babylon cities
Article Sidebar
Main Article Content
Abstract
Abstract
About thirty various viruses, bacteria, and parasites are the causes of sexually transmitted diseases (STDs). These diseases are spread predominantly by sexual contact, including vaginal, anal, and oral sex. This study aims to evaluate the efficiency of modern immunochromatographic strips in diagnosing Candida albicans, Trichomonas vaginalis, and Neisseria gonorrhea in Kerbala and Babylon cities and compare them with traditional diagnostic methods. The study started on 1 November 2022 and ended on 30 June 2023. This is a cross-sectional study constituted 300 patients (150 male and 150 female) seeking treatment for abnormal vaginal discharge, itching, dysuria, dyspareunia, urethritis, and prostatitis at private clinics in Kerbala and Babylon cities. The entire patient database was enclosed in a single questionnaire. Immunochromatography strips were used to detect Candida, Trichomonas, and Neisseria. The investigations achieved 144 positive cases of STDs distributed as 81, 43, and 20 positive samples for Candida albicans, Trichomonas vaginalis, and Neisseria gonorrhea respectively. Whilst, the remaining 156 negative samples may be referred to other causative agents. The highest infection among marital state was in married persons than unmarried. The study approved significantly increased STDs in patients who lived in urban areas than in rural areas. In conclusion, this study revealed that the new immunochromatography strip test was rapid and more sensitive and specific in diagnosis of T. vaginalis, N. gonorrhea, and C. albicans than routine conventional diagnostic tests.
Keywords: Trichomonas vaginalis, Neisseria gonorrhea, Candida albicans, immunochromatography
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The Journal of Medical and Oral Biosciences uses a Creative Commons Attribution (CC Attribution-ShareAlike 4.0) and its license of (CC BY-SA 4.0). This license allows the authors to hold ownership of the copyright of their articles.
Attribution-Share Alike 4.0 International License (CC BY-SA 4.0). 
Under the CC BY-SA 4.0 the authors are free to:
Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
No use, distribution or reproduction is permitted which does not comply with these terms.
https://creativecommons.org/licenses/by-sa/4.0/